Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Evotec and Harvard University form new alliance

Jan. 17, 2012

Trillium set to begin phase I TTI-1612 trial in Canada

Dec. 19, 2011

FDA approves new oxybutynin gel product

Dec. 12, 2011

ChemoCentryx begins new study of CCX-140 in diabetic nephropathy

Dec. 9, 2011

Primary endpoint met in Toviaz trial

Dec. 9, 2011

Spectrum Pharmaceuticals files IND with FDA for phosphate-binding agent

Dec. 7, 2011

New triterpenoid derivatives prepared by Concert Pharmaceuticals

Dec. 7, 2011

Novel mineralocorticoid receptor antagonists prepared by Pfizer

Dec. 5, 2011

Novartis discloses final results from EXIST-2 trial

Nov. 30, 2011

Phase III data support lixivaptan therapy in euvolemic hyponatremia

Nov. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...